{"cord_uid": "nomfciyu", "sourcedb": "PMC", "sourceid": "PMC7080179", "divid": "16", "text": "Convalescent plasma therapy utilizes plasma or whole blood from people who have been infected with viral diseases and recovered . This therapy has been used during outbreaks when no particular medicines or vaccines are available for treatment [ 67 ] . The use of convalescent plasma has been indicated to be an efficient therapeutic strategy for diseases like MERS - CoV [ 68 ] . Studies have been carried out to confirm its feasibility and safety in treating MERS ; however , the data are insufficient . There are a few drawbacks of this therapy , as often large - scale screening is required to obtain sufficient amount of antibodies from potential donors [ 69 ] .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 625, "end": 636}, "obj": "Gene"}]}